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Abstract
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Background—The Pediatric Heart Network is conducting a large international randomized trial
to compare aortic root growth and other cardiovascular outcomes in 608 subjects with Marfan
syndrome randomized to receive atenolol or losartan for 3 years. The authors report here the
echocardiographic methods and baseline echocardiographic characteristics of the randomized
subjects, describe the interobserver agreement of aortic measurements, and identify factors
influencing agreement.
Methods—Individuals aged 6 months to 25 years who met the original Ghent criteria and had
body surface area–adjusted maximum aortic root diameter (ROOTmax) Z scores > 3 were eligible
for inclusion. The primary outcome measure for the trial is the change over time in ROOTmax Z
score. A detailed echocardiographic protocol was established and implemented across 22 centers,
with an extensive training and quality review process.
Results—Interobserver agreement for the aortic measurements was excellent, with intraclass
correlation coefficients ranging from 0.921 to 0.989. Lower interobserver percentage error in
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ROOTmax measurements was independently associated (model R2 = 0.15) with better image
quality (P = .002) and later study reading date (P < .001). Echocardiographic characteristics of the
randomized subjects did not differ by treatment arm. Subjects with ROOTmax Z scores ≥ 4.5
(36%) were more likely to have mitral valve prolapse and dilation of the main pulmonary artery
and left ventricle, but there were no differences in aortic regurgitation, aortic stiffness indices,
mitral regurgitation, or left ventricular function compared with subjects with ROOTmax Z scores <
4.5.
Conclusions—The echocardiographic methodology, training, and quality review process
resulted in a robust evaluation of aortic root dimensions, with excellent reproducibility.
Keywords
Marfan syndrome; Aortic root; Echocardiography; Interobserver agreement
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Marfan syndrome (MFS) is a systemic disorder of connective tissue caused by mutations in
FBN1, the gene encoding fibrillin-1.1 The leading cause of mortality in MFS is
cardiovascular disease, including aortic root dilation and aortic dissection. The National
Heart, Lung, and Blood Institute–funded Pediatric Heart Network is conducting a
randomized trial to compare the rates of aortic root enlargement and other short-term
cardiovascular outcomes in children and young adults with MFS randomized to receive
atenolol or losartan for 3 years. The rationale and design of this randomized trial have been
reported.2
The primary outcome measure of this trial is the change over time (slope) in maximum
aortic root diameter (ROOTmax) Z score measured by echocardiography at the level of the
sinuses of Valsalva. Accurate and reproducible measurement of the aortic root diameter is
particularly important in patients with MFS because aortic root size is one of the best
predictors of cardiovascular outcome. Factors that may adversely affect intraobserver and
interobserver agreement of aortic measurements in patients with MFS include increasing age
and body size, pectus abnormality or scoliosis, and severity of aortic root dilation.
We report here the specifics of the echocardiographic methods used in this trial, including
the training and quality review process, a detailed analysis of the interobserver and
intraobserver agreement in baseline aortic measurements, and the factors influencing
agreement in this cohort. The large sample size, measurement of all aortic dimensions in
systole and diastole, as well as the analysis of multiple beats are distinguishing features of
this trial. A detailed description of the baseline clinical characteristics of the screened
population and enrolled subjects is being reported separately.3
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METHODS
Patients
Subjects enrolled in this trial2 were individuals aged 6 months to 25 years who met the
original Ghent criteria for MFS,4 with a body surface area (BSA)–adjusted ROOTmax Z
score > 3 and absolute ROOTmax < 5 cm. Patients with prior aortic surgery were excluded.
A total of 608 subjects were enrolled between February 2007 and February 2011. The study
protocol was approved by the institutional review board or institutional ethics board at each
participating center, and informed consent and assent were obtained, depending on age, from
patients and their parents or legal guardians before trial enrollment.
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The echocardiographic technical protocol and study manual were developed after consensus
was reached among several experts in the field. The detailed protocol is provided in the
online Appendix (available at www.onlinejase.com). Echocardiograms were performed on
study subjects at baseline and at 6 months, 1 year, 2 years, and 3 years after randomization
to either atenolol or losartan. Before baseline echocardiography, all patients on prophylactic
therapy for aortic root dilation underwent taper and washout according to protocol. The data
analyses presented here are based on the baseline echocardiographic studies only.
Patient length in centimeters and weight in kilograms were measured by an MFS trial study
coordinator at the time of echocardiography and were used to calculate BSA.5 An automated
vital sign device (Dinamap; GE Medical Systems, Waukesha, WI) was used to record
multiple right brachial blood pressures and heart rates during echocardiographic assessment.
Blood pressure and heart rate were recorded after the patient had been in a recumbent
position for 5 to 10 min, during or immediately after recording of aortic images for
calculation of stiffness indices. Four samples were obtained, the first of which was discarded
(because it is the least reliable). The other samples were averaged.
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Complete echocardiographic studies were performed using local instrumentation, transducer
selection, and machine settings that provided the optimal images on the basis of the
judgment of the ultrasonographer. Harmonic imaging and lateral gain were used when they
helped define structures such as endocardial borders. Specific instructions for image
optimization were given to the centers, including the following: use of zoom mode to
optimize screen resolution when anatomic structures were to be measured, recording of
transitions from full screen to zoom and from two-dimensional (2D) to spectral Doppler to
enable the core laboratory readers to identify structures and sample locations, use of fullscreen M mode to optimize distance-axis screen resolution, use of the highest sweep speed
on M-mode and spectral Doppler recordings to optimize time-axis screen resolution, use of
baseline velocity and wall-filter adjustment on spectral Doppler, adequate
electrocardiographic strip for documentation of heart rate, and recording without the local
measurements, if possible, to permit independent review by the core laboratory readers. For
each structural measurement, 6 to 10 cardiac cycles were recorded, and for color Doppler
evaluation of the valves, 10 to 15 cardiac cycles were recorded. ROOTmax was measured
locally in triplicate and averaged to calculate a Z score to determine eligibility before
randomization.
Core Laboratory Analysis
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Measurements were performed in the core laboratory on a microcomputer-based workstation
custom programmed for electronic caliper overlay of captured digital images for recording
(EchoTrace; Marcus Laboratories, Boston, MA). The aortic diameters were measured at
their maximum and minimum dimensions in systole and diastole from inner edge to inner
edge at the aortic valve annulus, aortic root at the sinuses of Valsalva, sinotubular junction,
and ascending aorta (Figure 1). Each of these eight measurements was performed in
triplicate by two independent observers.
The anteroposterior diameter of the distal thoracic aorta was measured at the level of the
diaphragm. The lateral diameter of the main pulmonary artery (MPA)6 was measured from a
parasternal imaging window. The durations of diastolic antegrade and retrograde flow in the
proximal and distal descending thoracic aorta were measured. Left ventricular (LV) size and
functional parameters were calculated according to American Society of Echocardiography
pediatric guidelines in the apical and parasternal short-axis views.6

J Am Soc Echocardiogr. Author manuscript; available in PMC 2014 June 01.
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Mitral valve prolapse (MVP) or tricuspid valve prolapse (TVP) was classified as present if
all or part of a valve leaflet was observed to pass through the plane of the valve annulus in
the parasternal long-axis imaging plane. Prolapse was classified as borderline if one of the
valve leaflets was observed to manifest posterior motion relative to the other leaflet without
passing through the plane of the valve annulus. The degree of mitral regurgitation (MR) and
aortic regurgitation (AR) were categorized qualitatively as mild or more, trivial, or none.
The eight averaged aortic measurements were reported for each of the two independent
observers. Z scores were available for the maximum dimensions only.7 Raw values and Z
scores were calculated for LV dimensions, volumes, mass, shortening fraction, and ejection
fraction.8,9
Percentage duration of diastolic flow reversal in the proximal and distal thoracic aorta was
calculated. The arterial pressure-strain elastic modulus10 and stiffness index11 were
calculated for the aortic root at the sinuses of Valsalva and the ascending aorta. The
averages of the systolic, diastolic, and mean blood pressures along with corresponding Z
scores (Boston Children’s Hospital normative database) were calculated.
Training and Quality Control
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The training process for site investigators included a face-to-face session with site
investigators and a webinar session during which samples of each recording were reviewed
in detail. An instructional CD-ROM was also distributed to all sites. As part of quality
control, each site went through a certification process whereby three local aortic root
measurements in addition to three full study protocol echocardiograms were reviewed at the
core laboratory. A detailed review letter with constructive feedback was provided to each
site.
Two core laboratory readers blinded to treatment assignment independently reviewed all
echocardiograms. Each study was graded for image quality (excellent, good, fair, or
unacceptable) and variation from protocol. A random subset (8%) of the studies was
reviewed twice by each core laboratory reader to assess intrareader agreement.
Statistical Methods
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Summary statistics are presented as mean ± SD or as median (interquartile range [IQR]).
Continuous variables were compared by treatment assignment and other characteristics (e.g.,
gender, family history of MFS) using Student’s t tests or Wilcoxon’s rank-sum tests for
approximately normally distributed and skewed variables, respectively. Categorical
variables were compared by treatment assignment and other subgroup factors using χ2 or
Fisher’s exact tests. To examine the associations of age and most echocardiographic indices,
we compared growing children (male < 16.0 years of age, female < 15.0 years of age) with
all others (male ≥ 16.0 years of age, female ≥ 15.0 years of age).12 For aortic elastic
modulus and stiffness index, we examined differences in outcomes by age using age
quartiles. Group comparisons that required age adjustment used continuous age and were
performed using analysis of covariance and logistic regression for continuous and
dichotomous measures, respectively. Echocardiographic and blood pressure Z scores for
BSA and/or age were derived from the Boston Children’s Hospital normative database and
compared with a healthy population mean of zero using a one-sample t test or Wilcoxon’s
signed-rank test. Interobserver and intraobserver agreement was estimated using intraclass
correlation coefficients (ICCs) and 95% confidence intervals. Agreement was also estimated
by a percentage error measurement, defined as the absolute value of the difference in the
two measurements divided by the mean of the two measurements multiplied by 100. To
identify factors that might influence interobserver agreement, a multivariate model using
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percentage error was constructed (defined as the absolute difference between raters divided
by the mean across raters multiplied by 100). To assess the robustness of the findings, a
secondary analysis of group differences and ICC estimates was conducted using weighting
according to image quality, with higher quality images having greater weight. This
secondary analysis had little impact on statistical inferences. Because of the large number of
comparisons, P values ≤ .01 were considered statistically significant. Analyses were
conducted using R version 2.14.1 (R Foundation for Statistical Computing, Vienna, Austria)
and SAS version 9.3 (SAS Institute Inc., Cary, NC).

RESULTS
Imaging of the aortic root was graded as excellent in 203 (33%), good in 357 (59%), and fair
in 47 (8%) patients. ROOTmax was measurable at least once in all echocardiograms and in
triplicate in 95%.
Agreement of the Echocardiographic Measurements
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Interobserver Agreement—Interobserver agreement for the aortic measurements was
excellent, with ICCs between the two core laboratory readers ranging from 0.921 to 0.989
(Table 1). Bland-Altman plots for interobserver agreement on all aortic measurements depict
excellent agreement, with a systematic bias wherein the primary reader obtained lower
values than the secondary reader (Figures 2A and 2B). This difference was slight, with mean
interobserver differences ranging from 0.5 to 2.0 mm. However, the plots do not reveal any
other systematic trends; specifically, the degree of agreement does not depend on the
magnitude of the measurement. The Bland-Altman plots were similar when absolute
dimensions, percentage error, and Z scores (not shown) were used.
The univariate analysis showed that the interobserver percentage error in ROOTmax
measurements was significantly lower by later read date and differed by center (P = .003 and
P < .001, respectively). The other variables examined include image quality, age at
echocardiography, BSA, absolute aortic root dimension, presence of pectus deformity or
scoliosis, number of Ghent criteria met, family history of MFS, and presence of FBN1
mutation. The multivariate model showed that lower interobserver percentage error in
ROOTmax measurements was only independently associated (model R2 = 0.15) with better
image quality (P = .002) and later study reading date (P < .001).
Stiffness Indices: Interobserver agreement for aortic stiffness indices was moderate, with
ICCs between the two core laboratory readers ranging from 0.59 to 0.71 for the ascending
aorta and aortic root (Table 1).
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One Beat versus Three Beats—In 95% of the echocardiographic examinations, the
primary reader obtained three measurements of the primary outcome (ROOTmax).
Percentage error was significantly lower for all averaged aortic measurements compared
with single-beat measurements, except for maximum aortic annulus and maximum
sinotubular junction (P ≤ .01; data not shown). For example, median percentage error for
three-beat versus single-beat ROOTmax dimension was 3.6 ± 2.6% versus 3.9 ± 3.0% (P = .
0002).
Intraobserver Agreement of the Aortic Root and MPA Measurements—
Intraobserver agreement for aortic root (Figure 3) and MPA measurements was excellent for
both primary and secondary readers, with all ICCs > 0.90.

J Am Soc Echocardiogr. Author manuscript; available in PMC 2014 June 01.
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Interobserver Agreement between the Local Echocardiographic Laboratory
and the Core Laboratory—The only reported measurement from the local laboratory
was the ROOTmax used to determine eligibility. Interobserver agreement for the ROOTmax
measurement between the local and core laboratories was near perfect (ICC, 0.988; 95%
confidence interval, 0.986–0.990; 3.36 ± 0.71 vs 3.35 ± 0.70; P = .55).
Echocardiographic Characteristics of the Randomized Cohort
The echocardiographic characteristics of the randomized subjects did not differ by treatment
arm (Table 2). By design, randomized subjects had larger aortic dimensions (Z score = 4.04;
IQR, 3.41 to 4.92) than healthy children (mean Z score = 0). MPA dimension Z scores were
also larger but to a lesser degree (mean Z score = 2.22 ± 1.34). All median and mean values
for LV size and function were within 1 standard deviation of mean values for healthy
children, except for diastolic septal and posterior wall thickness Z scores (−1.20 [IQR, −1.83
to 0.45] and −1.22 ± 1.02, respectively).
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MVP or borderline MVP was present in 366 of the subjects (61%). TVP or borderline TVP
was present in 270 of the subjects (49%). When MVP was present, there was more than a
twofold risk that TVP was also present (67% of those with MVP had TVP vs 28% of those
without MVP having TVP; relative risk, 2.37; P < .001). Mild or greater MR was present in
106 of the patients (18%). Mild or greater AR was uncommon, present in only 20 subjects
(3%). There were only four subjects with both mild or greater AR and MR.
Gender Differences—There were no significant gender differences in age in years (11.21
± 6.02 in male subjects vs 11.19 ± 6.77 in female subjects, P = .97) or BSA (1.31 ± 0.49 in
male subjects vs 1.24 ± 0.47 in female subjects, P = .10). MVP and mild or greater MR were
more common in female subjects (45% vs 33%, P < .01, and 25% vs 13%, P < .001,
respectively). Male subjects had larger aortic annular Z scores (1.89 ± 1.39 vs 1.57 ± 1.14, P
= .005). Aortic root elastic modulus and stiffness indices were higher in male subjects (685
[IQR, 449–1015] vs 551 [IQR, 359–774] and 8.6 [IQR, 6.1–13.4] vs 7.4 [IQR, 4.8–10.3],
respectively, P < .001 for both) but ascending aortic elastic modulus and stiffness index did
not vary by gender. There were no other significant gender differences in echocardiographic
characteristics of this cohort.
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Age at Randomization—The mean age at randomization was 11.2 ± 6.3 years. Older
teenagers and adults had lower Z scores compared with growing children (male < 16.0 years
of age, female < 15.0 years of age) for the aortic annulus (1.5 ± 1.1 vs 1.9 ± 1.3, P = .003),
sinotubular junction (1.7 [IQR, 1.0 to 2.5] vs 2.1 [IQR, 1.4 to 2.8], P = .003), ascending
aorta (0.5 [IQR, −0.1 to 1.1] vs 1.0 [IQR, 0.5 to 1.5], P < .001), and MPA (1.4 ± 1.3 vs 2.4 ±
1.3, P < .001). However there was no significant difference in ROOTmax Z scores between
children and adults. Systolic blood pressure Z scores were lower in children (−0.72 ± 0.99 vs
−0.42 ± 0.94 in adults, P = .001), but there was no difference in mean arterial blood pressure
or diastolic blood pressure Z scores. When analyzed by age quartiles, the elastic modulus
and stiffness index for both the ascending aorta and aortic root increased significantly with
age (Table 3).
Aortic Root Diameter Z Score—Table 4 shows the echocardiographic characteristics by
ROOTmax Z score dichotomized at 4.5. More than one third of the subjects (36%) had
ROOTmax Z scores ≥ 4.5. In these subjects, aortic annular, sinotubular junction, ascending
aortic, and MPA Z scores were higher than those in subjects with ROOTmax Z scores < 4.5.
Subjects with ROOTmax Z scores ≥ 4.5 were also more likely to have MVP and TVP. The
prevalence of MR and AR did not vary with ROOTmax Z score. LV end-diastolic and endsystolic volume Z scores were higher in subjects with ROOTmax Z scores ≥ 4.5, but LV
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shortening and ejection fractions were not different from those with smaller aortic root Z
scores. Results were similar for LV dimensions determined by M-mode imaging (data not
shown). There were no differences in stiffness indices and blood pressure measurements
between the two groups.

DISCUSSION
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Aortic root size is a major determinant in the clinical diagnosis of MFS13 and is the best
predictor of cardiovascular outcome.14 Varying methods to assess aortic root size by
echocardiography have been reported, including M-mode versus 2D imaging, systolic versus
diastolic measurements, and leading edge–to–leading edge versus inner edge–to–inner edge
measurements.6,15-17 Most adult echocardiography laboratories use the leading edge–to–
leading edge method in diastole, as recommended by the guidelines developed by the
American Society of Echocardiography in conjunction with the European Association of
Echocardiography.15 Similarly, a commonly used 2D pediatric nomogram (n = 52)
published by Roman et al.16 uses the leading edge–to–leading edge method in diastole.
However, recently published pediatric guidelines recommend inner edge–to–inner edge
measurements in systole.6 In addition, recently published pediatric normative databases
based on 2D echocardiography use inner edge–to–inner edge measurements of vessel
diameters.7,18,19 Our protocol included both systolic and diastolic measurements and used
the inner edge–to–inner edge 2D method and allometrically adjusted the systolic
measurements to BSA.7 Our results demonstrate that this is a feasible and highly
reproducible method to be used in a clinical trial involving pediatric and young adult
patients. The use of a common measurement technique for pediatric and adult patients
would be ideal for longitudinal studies over a wider age range; however, none of the
currently available normative databases cover the full age span. Previous investigators have
favored diastolic measurements for better reproducibility, but our study found excellent
agreement for both systolic and diastolic measurements of the aorta.
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Despite the difficulties inherent in multicenter data acquisition due to differing local styles,
as well as a patient population often challenging to image with echocardiography, a reliable
system was put into place with comprehensive training and quality review consistent with
the American Society of Echocardiography’s consensus statement on standards on
echocardiographic core laboratories,20 which resulted in excellent interobserver and
intraobserver agreement on the aortic measurements performed at the core laboratory. This
study was not designed to assess the overall interobserver variability between study centers.
Although prior studies have reported excellent agreement for aortic root diameter using Mmode echocardiography in relatively small cohorts of healthy children,21–23 our study is by
far the largest to report agreement, particularly in the MFS population. As expected, higher
image quality was associated with better agreement (smaller percentage error). Later reading
date was also associated with better agreement, which could be due to improved imaging
acquisition at the local sites over time and/or improved standardization of measurement at
the core laboratory over time. In the present study, two independent observers performed the
described eight measurements of the aorta on all echocardiograms obtained during the
course of the trial. A similar method was used by Selamet Tierney et al.24 to measure
ROOTmax in a much smaller MFS cohort (n = 63), but the measurements were made only in
systole, and the ascending aorta was not measured. Furthermore, interobserver agreement
improved when three beats were averaged compared with one or two beats, consistent with
the Pediatric Health Network Ventricular Volume Variability study on the variability of
echocardiographic indices of LV size and function.25 Improving the reproducibility of
outcome measures improves the likelihood of detecting treatment effects; therefore, we
recommend multiple-beat averaging whenever feasible in research settings, although the
impact in the clinical setting is not known.
J Am Soc Echocardiogr. Author manuscript; available in PMC 2014 June 01.
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Although the maximum and minimum aortic root and ascending aortic measurements by 2D
imaging were highly reproducible, the stiffness indices showed only moderate
reproducibility. This finding is in contrast to prior reports of excellent reproducibility of
stiffness indices of the ascending aorta using M-mode imaging of the aortic wall over five
cardiac cycles and using auto-detection software.26,27 However, this observation is in
alignment with the reported observation in the Ventricular Volume Variability study25 that
derived parameters on the basis of two or more measurements are invariably less
reproducible than the measurements themselves because of propagation of error. Assessment
of aortic root stiffness measured by M-mode echocardiography has been reported in patients
with bicuspid aortic valves, with a percentage of mean measurements between two observers
of 3.5% for stiffness index (n = 35) and variability of 14% in aortic root stiffness index
when measured at different times (n = 6).28 However, aortic root stiffness indices have not
been reported previously in patients with MFS and are therefore unique to our study.
We report the echocardiographic characteristics of a large cohort of children and young
adults with MFS and moderate aortic root dilation enrolled in a clinical trial of atenolol
versus losartan. Consistent with successful randomization, there were no differences in these
characteristics between the two treatment arms. Not surprisingly, subjects with more severe
aortic root dilation had a more severe echocardiographic profile overall, with greater
likelihood of having MVP, TVP, and dilation of the MPA and left ventricle.
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Our finding that MVP and mild or greater MR were more common in female patients is in
contrast to a prior study by Detaint et al.29; however, their cohort had a median age at
diagnosis of 22 years, twice that of our cohort. Our analysis suggests a higher prevalence for
mitral valve disease in young girls with MFS. Aortic annular dilation has been reported in
patients with MFS,30 but gender differences in the degree of dilation have not been reported
previously. Detaint et al. also reported that men presented earlier and with more severe
aortic dilation and related complications compared with women. Our finding that male
subjects had significantly stiffer aortic roots despite similar ROOTmax Z scores might
explain this difference in reported aortic outcomes in male subjects.
Limitations
By trial design, our cohort excluded patients with lower ROOTmax Z scores and with prior
or impending aortic surgery; therefore, the associations reported here are representative of
patients with MFS and moderate aortic root dilation and may not reflect the full spectrum of
the disorder. In addition, a large number of comparisons were conducted, and some findings
may be due to chance, even with our use of the more stringent significance level of .01.
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CONCLUSIONS
The echocardiographic methodology, training, and quality review process used in this
multicenter randomized clinical trial resulted in a robust evaluation of aortic root dimensions
with excellent reproducibility despite the challenges of a multicenter study design and the
imaging difficulties common in patients with MFS. This will optimize our ability to detect
differences in treatment effects between atenolol and losartan in children and young adults
with MFS.

Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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AR

Aortic regurgitation

BSA

Body surface area

ICC

Intraclass correlation coefficient

IQR

Interquartile range

LV

Left ventricular

MFS

Marfan syndrome

MPA

Main pulmonary artery

MR

Mitral regurgitation

MVP

Mitral valve prolapse

ROOTmax

Maximum aortic root diameter

TVP

Tricuspid valve prolapse

2D

Two-dimensional
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Figure 1.

Proximal aortic measurements in the parasternal long-axis view. The maximum and
minimum measurements were taken from inner edge to inner edge: (1) aortic valve
“annulus” at the hinge points of the leaflets; (2) aortic root at the largest diameter within the
sinuses of Valsalva; (3) sinotubular junction at the transition point from sinus to tubular
aorta; (4) ascending aorta at the level of the right pulmonary artery (RPA). AO, Aorta; LA,
left atrium; LV, left ventricle.
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Figure 2.

Bland-Altman plots for interobserver agreement for all maximum (A) and minimum (B)
aortic root measurements using absolute dimensions and percentage error. The BlandAltman plots graph the difference in absolute dimension or the percentage difference
between primary and secondary readers (primary minus secondary reader) versus the mean
across readers. The shaded 95% confidence bands are typically accepted as the range of
“clinical equivalence.” Agreement is considered very good if all data points are within these
bands. These plots emphasize the systematic bias, with values obtained from the primary
reader consistently lower than those from the secondary reader. STJ, Sinotubular junction.
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Figure 3.
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Bland-Altman plots for intraobserver agreement for minimum and maximum aortic root
measurements at the level of the sinuses of Valsalva.
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Table 1

ICCs between primary and secondary readers

NIH-PA Author Manuscript

n

ICC (95% CI)

Minimum aortic annular diameter

592

0.962 (0.955–0.967)

Maximum aortic annular diameter

589

0.921 (0.907–0.933)

Minimum aortic root diameter

600

0.987 (0.985–0.989)

ROOTmax

607

0.989 (0.987–0.990)

Minimum sinotubular junction diameter

487

0.952 (0.942–0.960)

Maximum sinotubular junction diameter

538

0.948 (0.939–0.956)

Minimum ascending aortic diameter

483

0.972 (0.966–0.976)

Maximum ascending aortic diameter

525

0.971 (0.966–0.976)

Ascending aorta elastic modulus*

480

0.626 (0.533–0.688)

Ascending aorta stiffness index*

480

0.589 (0.509–0.657)

Aortic root elastic modulus*

598

0.708 (0.658–0.752)

Aortic root stiffness index*

598

0.676 (0.619–0.724)

Variable

NIH-PA Author Manuscript

*

These indices were log transformed for this analysis.
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Table 2

Echocardiographic characteristics of randomized subjects in aggregate and by treatment arm

NIH-PA Author Manuscript

Aggregate (n = 608)
n

Characteristic

Value

Treatment A (n = 303)
n

Value

Treatment B (n = 305)
n

Value

P

NIH-PA Author Manuscript

Aortic annular maximum diameter Z
score

589

1.76 ± 1.30†

296

1.71 ± 1.24

293

1.81 ± 1.36

.32

Aortic annular maximum diameter
(cm)

589

2.01 ± 0.42

296

2.01 ± 0.42

293

2.00 ± 0.41

.79

ROOTmax Z score (sinuses of
Valsalva)

607

4.04 (3.41 to 4.92)†

303

4.04 (3.47 to 4.82)

304

4.04 (3.34 to 5.01)

.68*

ROOTmax (cm) (sinuses of Valsalva)

607

3.36 ± 0.71

303

3.37 ± 0.72

304

3.36 ± 0.71

.96

Aortic sinotubular junction
maximum
diameter Z score

552

1.98 (1.32 to 2.72)†

276

1.94 (1.35 to 2.58)

276

2.04 (1.30 to 2.85)

.14*

Aortic sinotubular junction
maximum diameter (cm)

552

2.41 ± 0.53

276

2.40 ± 0.54

276

2.43 ± 0.52

.51

Ascending aortic maximum
diameter Z score

543

0.88 (0.38 to 1.47)†

263

0.80 (0.37 to 1.38)

280

0.91 (0.40 to 1.56)

.13*

Ascending aortic maximum
diameter (cm)

543

2.30 (1.94 to 2.60)

263

2.30 (1.93 to 2.56)

280

2.30 (1.97 to 2.63)

.62*

Descending aortic maximum
diameter (cm)

592

1.31 ± 0.33

296

1.32 ± 0.34

296

1.31 ± 0.32

.92

Percentage duration of diastolic flow
reversal in PTA

319

17.8 (10.3 to 23.4)

158

17.3 (4.7 to 23.2)

161

18.3 (11.7 to 23.4)

.28*

Percentage duration of diastolic flow
reversal in DTA

513

0.0 (0.0 to 9.4)

259

0.0 (0.0 to 9.0)

254

0.0 (0.0 to 10.6)

.58*

MPA maximum diameter (cm)

512

2.36 ± 0.46

261

2.37 ± 0.47

251

2.34 ± 0.45

.47

MPA maximum diameter Z score

512

2.22 ± 1.34†

261

2.19 ± 1.36

251

2.26 ± 1.32

.55

Presence of AR

607

67 (11%)

302

35 (12%)

305

32 (11%)

.70

Among subjects with AR

67

35

32

.29

Trivial

47 (70%)

27 (77%)

20 (62%)

Mild or more

20 (30%)

8 (23%)

12 (38%)

Presence of MR

597

Among subjects with MR

384

384 (64%)

298

195 (65%)

195

299

189 (63%)

189

278 (72%)

149 (76%)

129 (68%)

Mild or more

106 (28%)

46 (24%)

60 (32%)

NIH-PA Author Manuscript

596

298

298

230 (39%)

Borderline

140 (24%)

64 (22%)

76 (25%)

Present

226 (38%)

120 (40%)

106 (36%)

551

276

MH = .07

.38

None

TVP

114 (38%)

.61
.09

Trivial

MVP

MH = .19

116 (39%)

275

MH = .45

.18

None

281 (51%)

143 (52%)

138 (50%)

Borderline

149 (27%)

66 (24%)

83 (30%)

Present

121 (22%)

67 (24%)

54 (20%)

MH = .66

LV size and function
LV end-diastolic volume Z score

521

−0.23 ± 1.38†

260

−0.25 ± 1.36

261
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Aggregate (n = 608)
n

Characteristic

NIH-PA Author Manuscript

LV end-systolic volume Z score

521

LV ejection fraction (%)
LV mass Z score

Value

Treatment A (n = 303)
n

−0.42 ± 1.36†

259

521

64.6 ± 6.4

518

−0.25 (−0.90 to 0.68)

Value

Treatment B (n = 305)
n

Value

P

− 0.43 ± 1.31

.93

−0.42 ± 1.40

262

260

64.4 ± 6.1

261

64.9 ± 6.6

.44

259

−0.22 (−0.99 to
0.66)

259

−0.27 (−0.87 to
0.71)

.79*

†
LV mass/volume ratio (g/mL)

519

0.92 ± 0.15

260

0.91 ± 0.15

259

0.92 ± 0.15

.83

LV end-diastolic dimension Z
score

585

0.70 (−0.14 to 1.65)†

291

0.71 (−0.30 to 1.63)

294

0.70 (0.01 to 1.72)

.28*

LV end-systolic dimension Z
score

585

0.35 (−0.53 to 1.22)†

291

0.31 (−0.71 to 1.28)

294

0.39 ( −0.44 to
1.19)

.33*

LV mass Z score (by M-mode
echocardiography)

585

−0.65 (−1.52 to 0.34)

291

−0.74 (−1.51 to
0.27)

294

− 0.59 (−1.56 to
0.39)

.46*

LV shortening fraction (%)

587

37.2 ± 5.1

292

37.2 ± 5.3

295

37.2 ± 5.0

.98

LV diastolic septal thickness Z
score

585

−1.20 (−1.83 to
−0.45)†

291

−1.15 (−1.79 to
−0.54)

294

−1.23 (−1.87 to
−0.37)

.78*

LV diastolic posterior wall
thickness Z score

585

−1.22 ± 1.02†

291

−1.23 ± 1.01

294

−1.21 ± 1.03

.84

Ascending aortic elastic modulus
(mm Hg)

492

318 (231 to 447)

237

319 (231 to 430)

255

317 (231 to 463)

.60*

Ascending aortic stiffness index

492

4.95 ± 2.78

237

4.81 ± 2.62

255

5.08 ± 2.92

.29

Aortic root elastic modulus (mm
Hg)

598

618 (407 to 914)

299

602 (386 to 887)

299

644 (431 to 970)

.112*

Aortic root stiffness index

598

8.2 (5.5 to 12.2)

299

7.9 (5.2 to 11.8)

299

8.5 (5.9 to 12.4)

.110*

Systolic blood pressure (mm Hg)

606

97.2 ± 14.3

303

97.2 ± 13.4

303

97.2 ± 15.1

.98

Systolic blood pressure Z score

604

−0.65 ± 0.98†

303

−0.69 ± 0.99

301

−0.61 ± 0.97

.30

Diastolic blood pressure (mm Hg)

606

58.6 ± 9.9

303

59.1 ± 9.9

303

58.1 ± 9.9

.22

Diastolic blood pressure Z score

604

0.32 ± 0.94†

303

0.34 ± 0.97

301

0.29 ± 0.91

.57

Mean blood pressure (mm Hg)

606

69.9 ± 15.4

303

70.5 ± 15.1

303

69.3 ± 15.8

.33

Mean blood pressure Z score

593

−0.25 ± 0.96†

298

−0.24 ± 1.01

295

−0.26 ± 0.92

.81

†

Stiffness indices

NIH-PA Author Manuscript

Data are expressed as mean ± SD or as median (IQR). All echocardiographic measurements are based on core laboratory interpretations. All aortic
measures reported are maximal dimensions.

DTA, Descending thoracic aorta; MH, Mantel-Haenszel; PTA, proximal thoracic aorta.

NIH-PA Author Manuscript

*

Nonparametric P value.

†

Aggregate values compared with norms: statistically different from healthy normal (Z = 0) at P < .05.
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Table 3

Ascending aortic and aortic root elastic modulus and stiffness index by quartiles of age

NIH-PA Author Manuscript

n

Age < 6.0 y

n

Age 6.0–10.8 y

n

Age 10.8–15.5 y

n

Age > 15.5 y

P

Ascending aortic
elastic
modulus (mm
Hg)

133

257 (197–338)

134

285 (221–389)

129

356 (264–454)

96

426 (324–582)

<.0001*†

Ascending aortic
stiffness index

133

4.48 ± 2.85

134

4.61 ± 2.89

129

5.10 ± 2.57

96

5.86 ± 2.60

<.001†

Aortic root elastic
modulus (mm Hg)

152

430 (312–614)

150

581 (389–867)

147

719 (469–1040)

149

821 (537–1224)

<.0001*†

Aortic root
stiffness index

152

6.13 (4.54–8.78)

150

7.88 (5.45–11.53)

147

8.90 (6.21–13.74)

149

9.75 (6.57–14.92)

<.0001*†

Characteristic

Data are expressed as median (IQR) or as mean ± SD.

*

Nonparametric P value.

†

Statistically significant (P < .01).
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Table 4

NIH-PA Author Manuscript

Echocardiographic outcomes by ROOTmax Z score
ROOTmax Z score < 4.5 (n = 387)

ROOTmax Z score ≥ 4.5 (n = 220)

n

Value

n

Value

P

Aortic annular maximum diameter Z score

376

1.41 ± 1.07

213

2.39 ± 1.44

<.0001†

ROOTmax Z score (sinuses of Valsalva)

387

3.55 (3.14 to 4.00)

220

5.32 (4.82 to 6.12)

<.0001*,†

Aortic sinotubular junction maximum diameter Z
score

357

1.65 (1.01 to 2.21)

195

2.79 (2.11 to 3.77)

<.0001*,†

Ascending aortic maximum diameter Z score

349

0.79 (0.30 to 1.26)

194

1.19 (0.59 to 1.84)

<.0001*,†

Descending aorta maximum diameter (cm)

377

1.33 ± 0.34

214

1.29 ± 0.31

.27

MPA maximum diameter Z score

323

2.01 ± 1.24

188

2.58 ± 1.43

<.0001†

Presence of AR

386

33 (9%)

220

34 (16%)

.011

Presence of MR

383

235 (61%)

213

148 (70%)

MVP

380

Characteristic

None

<.001

163 (43%)

67 (31%)

NIH-PA Author Manuscript

Borderline

94 (25%)

45 (21%)

Present

123 (32%)

103 (48%)

TVP

.05

215

348

MH < .001†

.003†

203

None

192 (55%)

89 (44%)

Borderline

95 (27%)

54 (27%)

Present

61 (18%)

60 (30%)

MH = .001†

LV size and function
LV end-diastolic volume Z score

339

−0.47 ± 1.18

181

0.22 ± 1.60

<.0001†

LV end-systolic volume Z score

339

−0.61 ± 1.32

181

−0.08 ± 1.37

<.0001†

LV ejection fraction (%)

339

64.5 ± 6.2

181

64.9 ± 6.8

.56

LV mass Z score

337

−0.43 (−1.00 to 0.42)

180

0.005 (−0.77 to 1.01)

<.0001*,†

LV mass/volume ratio (g/mL)

338

0.92 ± 0.15

180

0.90 ± 0.16

.23

LV shortening fraction (%)

375

37.2 ± 5.2

211

37.3 ± 5.1

.79

Ascending aortic elastic modulus (mm Hg)

315

310.5 (222.8 to 453.8)

177

336.8 (249.0 to 442.5)

.12*

Ascending aortic stiffness index

315

4.84 ± 2.74

177

5.15 ± 2.85

.23

Aortic root elastic modulus (mm Hg)

380

610.6 (403.2 to 882.1)

218

684.8 (410.3 to 1014.8)

.16*

Aortic root stiffness index

380

8.0 (5.5 to 11.2)

218

8.8 (5.4 to 13.3)

.144*

Stiffness indices

NIH-PA Author Manuscript

Data are expressed as mean ± SD or as median (IQR). All echocardiographic measurements are based on core laboratory interpretations.

MH, Mantel-Haenszel.
*

Nonparametric P value.

†

Statistically significant (P < .01).
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